搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
pharmaphorum
1 天
Job losses loom at Achilles as TIL therapy platform is cut
Employees at Achilles Therapeutics are bracing themselves for job losses after the UK biotech announced that it is dropping ...
pharmaphorum
1 天
Sanofi's tolebrutinib cuts MS progression by 31% in trial
Data from the HERCULES trial presented at the ECTRIMS conference in Copenhagen, Denmark, today showed that tolebrutinib was ...
pharmaphorum
1 天
5 patient travel strategies to impact enrolment diversity in clinical research
The challenge persists, but, with a renewed focus from regulatory bodies and trial sponsors alike on improving enrolment ...
pharmaphorum
1 天
J&J nets another key approval for blockbuster hope Rybrevant
J&J's high expectations for Rybrevant are driven mainly by its August approval with Lazcluze, which outperformed Tagrisso in ...
pharmaphorum
1 天
Astellas brings its first digital health product to US
Astellas is ready to launch its first digital health offering in the US, a toolkit dedicated to providing at-home monitoring ...
pharmaphorum
2 天
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
The Centers for Medicare & Medicaid Services (CMS) has said it will announce the next 15 drugs in scope for the second round ...
pharmaphorum
3 天
Noom offers cut-price compounded GLP-1 drug for obesity
Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet ...
pharmaphorum
3 天
After FDA no, MSD/Daiichi post new data with lung cancer ADC
The result is a welcome endorsement of patritumab derxutecan's potential after the HER3-directed antibody-drug conjugate (ADC ...
pharmaphorum
2 天
Vanda slams FDA rejection of gastroparesis drug
The FDA has declined to approve Vanda Pharma's tradipitant for delayed gastric emptying (gastroparesis), prompting a furious ...
pharmaphorum
3 天
The booming medical device sector: How well are suppliers adapting to new regulatory demands?
Medical device companies are dealing with the impact of increasing regulations in a number of ways, including the ...
pharmaphorum
2 天
Organon makes dermatology play with $1.2bn Dermavant buyout
Organon is paying $175 million upfront to buy Roivant's dermatology unit Dermavant and its topical psoriasis therapy Vtama, ...
pharmaphorum
2 天
Supply chain resilience in pharma: Delivering consistency amidst global events
Global events can pose significant challenges to the supply of APIs, and thus the continuity of drug supply. Any disruption ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈